← Back to Search

Corticosteroid

Sarcoidosis related Calcium Dysregulation for Sarcoidosis

Phase 2 & 3
Waitlist Available
Led By Marc A Judson, MD
Research Sponsored by Albany Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than 18 years old.
Able to understand English to the point of comprehending the informed consent form.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights

Study Summary

ACTHAR Gel has activity in sarcoidosis associated hypercalciuria and calcium dysregulation.

Eligible Conditions
  • Sarcoidosis
  • Hypercalcemia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction of 24 hour urine calcium
Secondary outcome measures
Change in 1,25 di-hydroxy Vitamin D during 12 week ACTHAR GEL treatment
Change in Sarcoidosis Health Questionnaire during 12 week ACTHAR GEL treatment
Change in Short Form-36 during 12 week ACTHAR GEL treatment
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sarcoidosis related Calcium DysregulationExperimental Treatment1 Intervention
Subjects with Sarcoidosis associated calcium dysregulation will be administered 80 units of Acthar Gel (adrenocorticotropic hormone) twice a week for 12 weeks. Clinical visits will be scheduled for -30 days, day of 1st dose and 4,8,12 and 16 week after 1st dose to monitor the health of subjects.

Find a Location

Who is running the clinical trial?

Albany Medical CollegeLead Sponsor
91 Previous Clinical Trials
11,487 Total Patients Enrolled
3 Trials studying Sarcoidosis
410 Patients Enrolled for Sarcoidosis
Marc A Judson, MDPrincipal InvestigatorAlbany Medical College
3 Previous Clinical Trials
46 Total Patients Enrolled
3 Trials studying Sarcoidosis
46 Patients Enrolled for Sarcoidosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Mar 2025